📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
In 2024, CM Hospitalar completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
CM Hospitalar has also provided a category-level breakdown for 4 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore CM Hospitalar’s data sources below and access millions more through our Disclosure Search.
In 2024, the total operational greenhouse gas (GHG) emissions ofCM Hospitalar amounted to11,853.1metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of CM Hospitalarincreased by 12.46%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2024, the total Scope 1 emissions of CM Hospitalar were 8,153.5 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Since 2021, CM Hospitalar's Scope 1 emissions have decreased by 30.33%, reflecting a declining long-term trend in Scope 1 emissions over time.ab
Compared to the previous year(2023), CM Hospitalar's Scope 1 emissions increased by 5.02%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2024, CM Hospitalar reported Scope 2 greenhouse gas (GHG) emissions of 3,699.6 tCOâ‚‚e using the location-based method.a
Compared to the previous year(2023), CM Hospitalar's Scope 2 emissions(Location-Based) rose by 33.25% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya
In 2024, CM Hospitalar reported its Scope 2 emissions using the location-based method.a
In 2024, CM Hospitalar reported 7,599.43 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of CM Hospitalar includes a breakdown across 4of the 15 Scope 3 categories defined by the GHG Protocol,matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2024, CM Hospitalar reported total Scope 3 emissions of 7,599.43 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Approximately 100%of these emissions originated from upstream activities such as purchased goods and capital goods, while 0%came from downstream activities like product use, distribution, and end-of-life treatment.a
Since 2021, CM Hospitalar's Scope 3 emissionshave increased by 68.89%, reflecting a rising long-term trend in Scope 3 emissions over time.ab
Compared to the previous year (2023), CM Hospitalar's Scope 3 emissions increased by 44.33%, suggesting that the company faced challenges in reducing emissions across its value chain.a
In 2024, CM Hospitalar reported emissions for 4 out of the 15 Scope 3 categories defined by the GHG Protocol.a
The limited disclosure restricts visibility into specific emission sources across the company's value chain.
In 2024, the largest contributors to CM Hospitalar's Scope 3 emissions were:a
In 2024, CM Hospitalar reported Scope 1 greenhouse gas (GHG) emissions of 8,153.5 tCOâ‚‚e and total revenues of USD 1,875 millions. This translates into an emissions intensity of 4.35 tCOâ‚‚e per millions USD.a
In 2024, CM Hospitalar reported a Scope 1 emissions intensity of 4.35 tCOâ‚‚e per millions USD. Compared to the peer group median of 1.32, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2024, CM Hospitalar ranked 23 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
This places CM Hospitalar among the least efficient performers, with one of the highest emissions intensities in its sector.a
In 2024, CM Hospitalar reported a total carbon footprint of 19,452.53 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 23.08% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to CM Hospitalar's total carbon footprint was Scope 1 emissions, accounting for 41.91% of the company's total carbon footprint, followed by Scope 3 emissions at 39.07%.a